NCNA News and Press, NuCana plc From 03/20/24

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024 Randomized Phase 2 Study of 171 Second-Line Colorectal Cancer Patients Fully Recrui...

2024-03-14 06:12:00 ET These Are the Top Technical Indicators to Use When Trading Penny Stocks Trading penny stocks offers a unique opportunity for investors to gain significant returns on their investment, despite the generally lower price point of these stocks. However, navigating the...

EDINBURGH, United Kingdom, Feb. 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at TD Cowen’s 44th Annual Health Care Conference. Even...

EDINBURGH, United Kingdom, Feb. 06, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference....

2024-01-03 02:39:07 ET Summary NCNA is a beaten-down stock for numerous reasons, including failure of its prior lead candidate (Acelarin) in two phase 3 trials, as well as a limited cash runway. However, there are good reasons to believe that NCNA's current lead candidate, NUC-337...

2023-11-16 16:43:51 ET More on NuCana Seeking Alpha’s Quant Rating on NuCana Historical earnings data for NuCana Financial information for NuCana For further details see: NuCana GAAP EPS of -£0.13

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Data Pipeline Continues to Advance with Data Updates Expected for all Programs in 2024 Well Capitalized with Anticipated Cash Runway into 2025 EDINBURGH, United K...

The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...

NuCana plc (NCNA) is expected to report $-0.13 for Q3 2023

2023-11-10 16:06:50 ET More on NuCana NuCana Q2 Earnings: Recent Updates Bode Poorly, Not Worth The Risk For further details see: NuCana gets approval to transfer its listing to Nasdaq Capital Market